Dennis R. Benjamin - Concepedia

Author

Dennis R. Benjamin

Seagen (United States)

Also Known As

Benjamin, Dennis R., Dennis Benjamin, Dennis R Benjamin, Dennis R. Benjamin

Publications

3.8K

Citations

H-Index

Concepts

All Affiliations

Seagen (United States)Fred Hutch Cancer Center University of Oxford GlaxoSmithKline (United States)

About

Dennis R. Benjamin is an author at Seagen (United States) specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	1.4K
2	Cell Biology	3	3	613
3	Natural Sciences	2	2	858
4	Biochemistry	2	2	211
5	Biomolecular Engineering	1	1	456

Dennis R. Benjamin

Publications

3.7K

Citations

H-Index

Page 1

	Year	Citations
Design, synthesis and selection of DNA-encoded small-molecule libraries Matthew Clark, Raksha Acharya, Christopher C. Arico-Muendel, Nature Chemical Biology Dna NanotechnologyNatural SciencesSynthetic BiologyDna ReplicationMolecular Biology	2009	675
Contribution of Linker Stability to the Activities of Anticancer Immunoconjugates Stephen C. Alley, Dennis R. Benjamin, Scott C. Jeffrey, Bioconjugate Chemistry ImmunologyImmunotherapyTumor BiologyAmide LinkersMedicinal Chemistry	2008	456
SGN-CD33A: a novel CD33-targeting antibody–drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML May S.K. Sutherland, Roland B. Walter, Scott C. Jeffrey, Blood	2013	381
Intracellular Activation of SGN-35, a Potent Anti-CD30 Antibody-Drug Conjugate Nicole M. Okeley, Jamie B. Miyamoto, Xinqun Zhang, Clinical Cancer Research	2010	381
Intracellular Released Payload Influences Potency and Bystander-Killing Effects of Antibody-Drug Conjugates in Preclinical Models Li Fu, Kim K. Emmerton, Mechthild Jonas, Cancer Research ImmunologyImmunotherapyTumor BiologyPayload Influences PotencyBystander-killing Effects	2016	302
Detection and selective dissociation of intact ribosomes in a mass spectrometer Adam A. Rostom, Paola Fucini, Dennis R. Benjamin, Proceedings of the National Academy of Sciences	2000	206
A novel family ofras-binding domains Chris P. Ponting, Dennis R. Benjamin Trends in Biochemical Sciences Structural BioinformaticsProtein FoldingMolecular BiologyMolecular RecognitionMedicine	1996	206
Development of orally active inhibitors of protein and cellular fucosylation Nicole M. Okeley, Stephen C. Alley, Martha E. Anderson, Proceedings of the National Academy of Sciences Vitro FucosylationGlycobiologyImmunologyImmunotherapyTumor Biology	2013	183
The Pharmacologic Basis for Antibody-Auristatin Conjugate Activity Stephen C. Alley, Xinqun Zhang, Nicole M. Okeley, Journal of Pharmacology and Experimental Therapeutics	2009	131
SGN–LIV1A: A Novel Antibody–Drug Conjugate Targeting LIV-1 for the Treatment of Metastatic Breast Cancer Django Sussman, Leia M. Smith, Martha E. Anderson, Molecular Cancer Therapeutics Metastatic Breast CancerBreast OncologyDrug TargetingNovel Antibody-drug ConjugateImmunology	2014	128

Page 1